advertise

Friday 13 February 2015

Generic Drugs Market in Japan 2015-2019 - Worldwide Market size, share, trend, growth, analysis and Research Report

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us
A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs is 50-70 percent lower than that of their brand-name counterparts, while meeting the very same standards of safety, quality, and efficacy as the innovator drugs. 

Generic drugs help the manufacturer by eliminating the need to develop and market a new drug. As the patent approaches expiration, manufacturers can apply to the FDA for approval to manufacture and sell generic versions of the drug. Generic drugs are equal to and within the bioequivalence range of branded drugs.
Latest analysts forecast the Generic Drugs market in Japan to grow at a CAGR of 8.16 percent over the period 2014-2019.
Covered in this Report
The Generic Drugs market in Japan can be divided into three segments: Generic Prescription Medicines, Super Generics, and Biosimilars. This report covers the present scenario and the growth prospects of the Generic Drugs market in Japan for the period 20152019. To calculate the market size, the report considers the revenue generated from the following segments:
Generic Prescription Medicines
Super Generics
Biosimilars
Latest report, the Generic Drugs market in Japan 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the Generic Drugs market in Japan and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Key Vendors
Meiji Seika Pharma
Nichi-Iko Pharmaceutical
Nipro Pharma
Sawai Pharmaceuticals
Teva Pharmaceutical Industries
Towa Pharmaceutical
Other Prominent Vendors
Actavis
Daiichi Sankyo
Daito Pharmaceutical
Eisai
Fuji Pharma
GlaxoSmithKline
Hikari Pharmaceutical
Hospira
Mylan
Nihon Generic
Nippon Chemipher
Nippon Kayaku
Nissin Pharmaceutical
Ohara Pharmaceutical
Pfizer
Sandoz
Taiyo Yakuhin
Takeda Pharmaceutical
Zensei Pharmaceutical Industries
Market Driver
Increase in Number of Patent Expiries
For a full, detailed list, view our report.
Market Challenge
Intense Competition among Vendors
For a full, detailed list, view our report
Market Trend
Increase in M&A
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)